Contract research and manufacturing organisation, Foster Delivery Science, and manufacturer ProMed Pharma have announced a commercial partnership to provide comprehensive contract services for pharmaceutical and combination device applications.
The partnership will see the companies offering thermoplastic and silicone formulation development through production of drug delivery components.
Foster Delivery Science focuses on the blending and extrusion of melt processable polymers and active pharmaceutical ingredients (APIs). These include water soluble, bioresorbable and biodurable thermoplastic formulations.
ProMed Pharma offers advice in silicone formulation technologies, and is a provider of injection-moulded drug delivery components. The companies’ collaboration will entail marketing, business development and technical services for a comprehensive range of drug delivery materials and processing technologies.
Rob Sterling, director of Business Development for Foster Delivery Science said: “Thermoplastics and silicones offer unique benefits for drug delivery applications. Processing these materials with APIs requires different equipment and expertise. This collaboration allows our customers to access a broad range of resources to achieve the best results for their application.”
Dr. James Arps, director of ProMed Pharma said: “ProMed and Foster have been working on novel drug delivery technologies for many years and we look forward to enhancing our collaborative efforts in support of our customers.”